Viral Vector Manufacturing Market: Growth, Trends, and Key Insights 2025 | Top key players - Oxford BioMedica, CGT Catapult.

The Global Viral Vector Manufacturing Market reached USD 0.9 billion in 2022 and is expected to reach USD 3.8 billion by 2031 growing with a CAGR of 20.3% during the forecast period 2024-2031.

Viral Vector Manufacturing Market report, published by DataM Intelligence, delivers detailed insights and analysis on major market trends, growth prospects, and emerging challenges. With a strong focus on providing actionable intelligence, DataM Intelligence enables businesses to make well-informed decisions and maintain a competitive edge. By blending both qualitative and quantitative research approaches, the company offers thorough reports that support clients in navigating complex market environments, driving strategic expansion, and capitalizing on new opportunities in today's rapidly evolving global landscape.

The Viral Vector Manufacturing Market involves the production of viral vectors, which are used in gene therapies and vaccines. These vectors deliver genetic material into cells to treat genetic disorders or enhance immune responses. With advancements in biotechnology, the market is growing rapidly, driven by increasing demand for gene-based treatments and innovative vaccine development across the healthcare sector.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/viral-vector-manufacturing-market?sz

Market Opportunities and Growth Drivers:

Increasing Adoption of Gene and Cell Therapies Drives the Growth of the Viral Vector Manufacturing Market

Gene and cell therapies have garnered significant attention in recent years because of their potential to treat a variety of diseases, including genetic disorders, cancer, and rare diseases. Central to these therapies are viral vectors, which play a key role in delivering therapeutic genes into target cells. As the adoption of gene and cell therapies continues to grow, so does the demand for viral vectors, driving the expansion of the market.

Viral Vector Manufacturing Market Recent Development:

On June 29, 2023, Donaldson Company, Inc., a global leader in filtration products and solutions, announced its acquisition of Univercells Technologies. The acquisition enhances Donaldson's capabilities by adding Univercells' innovative biomanufacturing solutions, which support the research, development, and commercial production of cell and gene therapies.

On June 12, 2023, Charles River Laboratories International, Inc. partnered with Curigin, a Korean biotechnology company focused on developing cutting-edge oncolytic RNA interference (RNAi) gene therapies. The collaboration aims to leverage Charles River's expertise in contract development and manufacturing services (CDMO) to support Curigin's adenoviral vector production for its preclinical and clinical trials.

List of the Key Players in the Viral Vector Manufacturing Market:

Sanofi SA, Thermo Fisher Scientific Inc., Cobra Biologics Ltd, Lonza Group Ltd, Merck & Co., Oxford BioMedica, CGT Catapult, UniQure NV, FUJIFILM Diosynth Biotechnologies, and Spark Therapeutics Inc.

Research Process:

Both primary and secondary data sources have been used in the global Viral Vector Manufacturing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/viral-vector-manufacturing-market

Segment Covered in the Viral Vector Manufacturing Market:

By Type: Retroviral Vectors, Adenoviral Vectors, Adeno-Associated Viral Vectors, Other Viral Vectors.

By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases.

By Application: Gene Therapy, Vaccinology.

By End User: Pharmaceutical and Biopharmaceutical Companies, Research Institutes.

Regional Analysis for Viral Vector Manufacturing Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

People Also Ask:

Most Frequently Asked Questions in the Viral Vector Manufacturing Market Research Industry:

➠ What are the global figures for sales, production, consumption, imports, and exports in the Viral Vector Manufacturing market?

➠ Who are the top manufacturers in the global Viral Vector Manufacturing industry, and what is their current status in terms of production capacity, output, sales performance, pricing structure, cost analysis, profit margins, and overall revenue?

➠ What key opportunities are available for vendors in the Viral Vector Manufacturing market, and what challenges are they likely to encounter?

➠ Which application areas, end-user segments, or product types are projected to experience significant growth, and how is the market share distributed among them?

➠ What are the major drivers and barriers influencing the growth trajectory of the Viral Vector Manufacturing market?

➠ What are the primary sales, marketing, and distribution strategies used across the global Viral Vector Manufacturing industry landscape?

Browse More Reports: https://www.datamintelligence.com/research-report/viral-vector-manufacturing-market

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.